Skip to main content

Table 1 Ex-vivo analysis of CD4 + , CD8 + T cells and B cells (CD20 + ) from malaria patients and control individuals

From: Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil

 Cells

Malaria

Controls

CD4+

45,6 ± 15,7

45,3 ± 12,4

CD8+

23,4 ± 7,9

24 ± 10,3

CD20+

20,1 ± 22,9

10,7 ± 9,6

  1. (Mean ± standard deviation).